1

Current Status of Proton Beams Therapy in Japan #2Current Status of Proton

Beams Therapy in Japan #2

The Japan – Russia Cooperation SeminarApril 30, 2013 (Tue)-Moscow, Russia

The Japan – Russia Cooperation SeminarApril 30, 2013 (Tue)-Moscow, Russia

Vice President Sumitomo Heavy Industries, Ltd.

Vice President Sumitomo Heavy Industries, Ltd.

Yukio Kumata .Yukio Kumata .

2

Head Office Tokyo

Nagoya Works Yokosuka WorksSaijo Works

Chiba Works

Tanashi Works

Okayama Works

Niihama Factory- Industry Equipment Division-

Niihama Factory- Industry Equipment Division-

HQ： 1-1, Osaki 2-chome, Shinagawa-ku, Tokyo, Japan (ThinkPark Tower)

Founded： Nov.20, 1888Incorporated：Nov.1, 1934Capital： JPY30,871MNo. of Employee：18,139Group：Sumitomo Corp.

Sumitomo Mitsui Banking Corp.Sumitomo ChemicalsNEC Corp.Asahi Breweries

Company ProfileCompany Profile

3

DiagnosisDiagnosis Semi-conductor

AnimalPET

CyclotronRadiotracer Production

System

Auto injector

SynthesizerSynthesizer

PETCyclotronSystem

MIP-100TreatmentTreatment

Proton Therapy System

Heavy Ion Therapy System

Sumitomo Medical Systems

BNCTSystem

Auto QC /Auto QC /DispenserDispenser

4

Positron Nuclide (18F, 11C , 15O,13N ) PET Scanner

Positron (+)

γray

Electron (-)

γray γray

What is Positron Emission Tomography (PET)?What is Positron Emission Tomography (PET)?<Principle>

Suspected Lung cancer Benign

After treatment/esophageal cancerMetastatis Lung cancer

Malignant lymphoma

5

Features of Proton Therapy

1. Surgery

2. Chemotherapy

Cancer therapeutic methods

Features of Radio therapy1)Good clinical result2)High QOL after treatment3)Applicable for many tumors

X-ray

γ-ray

Proton

Carbon

3. Radio therapy

Electromagnetic Beam

Particle Beam

X ray

Depth in Body

Dose

ProtonProton

Proton(SOBP）

TumorProton (Bragg Peak)

Normal Tissue Normal Tissue

Dose distribution by X-ray therapy

Target (Tumor site)

Dose distribution by Proton therapy

Ｘ-ray Proton

◇Stop at a certain depth （no damage to vital organ）◇Less damage at the surface◇Concentrate energy on tumor site

Bragg Peak

Features

6

Cyclotron-based BNCT System

30 MeV Cyclotron Target Station Patient Positioning

① Kyoto University Reactor Institute （KUR)

2012～ Clinical Trial started

② Southern Tohoku Hospital

2015～ Clinical Trial will start

Sumitomo

Reference in Japan

7

СПАСИБО !СПАСИБОСПАСИБО !